Watch OSCR. Know when insiders buy.
One email the day a filing lands. Free.
Work order
48
WATCH · insiders 25, shorts 71
Insiders, 90 days
−$23.4M
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E 24.8DIV YIELD —FCF YIELD —REV TTM $15.3B +42.8%NET INCOME $550.7MNET CASH $3.6B52W 10.85 – 32.76SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $4.9B | +70.4% | — | $388.6M | $361.8M | — | 1.10 | $2.1B | $11.8M | $2.1B | Aug 7 |
| Q1 2026 · Mar 31 | $4.6B | +52.6% | — | $704.1M | $679M | +146.7% | 2.07 | $2.6B | $8.8M | $2.6B | May 7 |
| Q4 2025 · Dec 31derived | $2.8B | +17.3% | — | −$333.7M | −$352.6M | — | -1.34 | $671.9M | $9.1M | $662.8M | Feb 13 |
| Q3 2025 · Sep 30 | $3B | +23.2% | — | −$129.3M | −$137.4M | — | -0.53 | −$964.7M | $9M | −$973.7M | Nov 6 |
| Q2 2025 · Jun 30 | $2.9B | +29.0% | — | −$230.5M | −$228.4M | −506.3% | -0.89 | $509.1M | $9.3M | $499.8M | Aug 7 |
| Q1 2025 · Mar 31 | $3B | +42.2% | — | $297.1M | $275.3M | +55.2% | 0.92 | $878.5M | $9M | $869.5M | May 7 |
| Q4 2024 · Dec 31derived | $2.4B | +67.1% | — | −$147.7M | −$153.5M | — | -0.55 | $346.8M | $6.8M | $340M | Feb 13 |
| Q3 2024 · Sep 30 | $2.4B | +68.3% | — | −$48.4M | −$54.6M | — | -0.22 | −$500.1M | $7.6M | −$507.7M | Nov 6 |
| Q2 2024 · Jun 30 | $2.2B | — | — | $67.8M | $56.2M | — | 0.20 | $497.2M | $7.6M | $489.6M | Aug 7 |
| Q1 2024 · Mar 31 | $2.1B | — | — | $185.6M | $177.4M | — | 0.62 | $634.4M | $6M | $628.4M | May 8 |
| Q4 2023 · Dec 31derived | $1.4B | — | — | −$145.5M | −$150M | — | -0.67 | $296.9M | $6.1M | $290.8M | Feb 13 |
| Q3 2023 · Sep 30 | $1.4B | — | — | −$58.2M | −$65.4M | — | -0.29 | −$1.1B | $6.5M | −$1.2B | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $11.7B | — | −$396.4M | −$443.2M | -3.8% | -1.69 | $1.1B | $36.4M | $1.1B | — | — |
| FY2024 · to Dec 31 | $9.2B | — | $57.3M | $25.4M | 0.3% | 0.10 | $978.2M | $27.9M | $950.3M | — | — |
| FY2023 · to Dec 31 | $5.9B | — | −$235.6M | −$270.7M | -4.6% | -1.22 | −$272.2M | $25.6M | −$297.7M | — | — |
| FY2022 · to Dec 31 | $4B | — | −$589.9M | −$606.3M | -15.3% | -2.85 | $380.3M | $29M | $351.3M | — | — |
| FY2021 · to Dec 31 | $1.8B | — | −$544.5M | −$572.6M | -31.1% | -3.20 | −$181.7M | $25.9M | −$207.6M | $0 | — |
| FY2020 · to Dec 31 | $462.8M | — | −$402.3M | −$406.8M | -87.9% | -14.16 | $222.7M | $14M | $208.7M | $0 | — |
Every number comes from Oscar Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.